Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis.
anti nuclear antibody (ANA)
autoantibodies
autoantigen
biomarker
juvenile idiopathic arthiritis
juvenile idiopathic arthiritis associated uveitis
uveitis
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
11
2022
accepted:
16
12
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
Many children with juvenile idiopathic arthritis (JIA) have autoantibodies, targeting nuclear components (anti-nuclear antibodies, ANA). ANA in JIA is associated with uveitis, an eye inflammation which may cause permanent vision impairment if not detected and treated. However, ANA-testing is neither specific nor sensitive enough to be a clinically reliable predictor of uveitis risk, and the precise autoantigens targeted by ANA in JIA are largely unknown. If identified, specific autoantibodies highly associated with uveitis could be used as biomarkers to facilitate identification of JIA patients at risk. Antibodies from six ANA-positive, oligoarticular JIA patients, with and without uveitis, were explored by two large-scale methods: (1) screening against 42,100 peptides on an autoimmunity profiling planar array, and (2) immunoprecipitations from cell lysates with antigen identification by mass spectrometry. Three hundred thirty-five peptide antigens, selected from proteins identified in the large-scale methods and the scientific literature were investigated using a bead-based array in a cohort of 56 patients with oligoarticular- or RF-negative polyarticular JIA, eight of which were having current or previous uveitis. In the planar array, reactivity was detected against 332 peptide antigens. The immunoprecipitations identified reactivity towards 131 proteins. Only two proteins were identified by both methods. In the bead-based array of selected peptide antigens, patients with uveitis had a generally higher autoreactivity, seen as higher median fluorescence intensity (MFI) across all antigens, compared to patients without uveitis. Reactivity towards 17 specific antigens was significantly higher in patients with uveitis compared to patients without uveitis. Hierarchical clustering revealed that patients with uveitis clustered together. This study investigated autoantigens in JIA and uveitis, by combining two exploratory methods and confirmation in a targeted array. JIA patients with current or a history of uveitis had significantly higher reactivity towards 17 autoantigens and a generally higher autoreactivity compared to JIA patients without uveitis. Hierarchical clustering suggests that a combination of certain autoantibodies, rather than reactivity towards one specific antigen, is associated with uveitis. Our analysis of autoantibodies associated with uveitis in JIA could be a starting point for identification of prognostic biomarkers useful in JIA clinical care.
Sections du résumé
Background
UNASSIGNED
Many children with juvenile idiopathic arthritis (JIA) have autoantibodies, targeting nuclear components (anti-nuclear antibodies, ANA). ANA in JIA is associated with uveitis, an eye inflammation which may cause permanent vision impairment if not detected and treated. However, ANA-testing is neither specific nor sensitive enough to be a clinically reliable predictor of uveitis risk, and the precise autoantigens targeted by ANA in JIA are largely unknown. If identified, specific autoantibodies highly associated with uveitis could be used as biomarkers to facilitate identification of JIA patients at risk.
Methods
UNASSIGNED
Antibodies from six ANA-positive, oligoarticular JIA patients, with and without uveitis, were explored by two large-scale methods: (1) screening against 42,100 peptides on an autoimmunity profiling planar array, and (2) immunoprecipitations from cell lysates with antigen identification by mass spectrometry. Three hundred thirty-five peptide antigens, selected from proteins identified in the large-scale methods and the scientific literature were investigated using a bead-based array in a cohort of 56 patients with oligoarticular- or RF-negative polyarticular JIA, eight of which were having current or previous uveitis.
Results
UNASSIGNED
In the planar array, reactivity was detected against 332 peptide antigens. The immunoprecipitations identified reactivity towards 131 proteins. Only two proteins were identified by both methods. In the bead-based array of selected peptide antigens, patients with uveitis had a generally higher autoreactivity, seen as higher median fluorescence intensity (MFI) across all antigens, compared to patients without uveitis. Reactivity towards 17 specific antigens was significantly higher in patients with uveitis compared to patients without uveitis. Hierarchical clustering revealed that patients with uveitis clustered together.
Conclusion
UNASSIGNED
This study investigated autoantigens in JIA and uveitis, by combining two exploratory methods and confirmation in a targeted array. JIA patients with current or a history of uveitis had significantly higher reactivity towards 17 autoantigens and a generally higher autoreactivity compared to JIA patients without uveitis. Hierarchical clustering suggests that a combination of certain autoantibodies, rather than reactivity towards one specific antigen, is associated with uveitis. Our analysis of autoantibodies associated with uveitis in JIA could be a starting point for identification of prognostic biomarkers useful in JIA clinical care.
Identifiants
pubmed: 36699287
doi: 10.3389/fped.2022.1091308
pmc: PMC9869058
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1091308Informations de copyright
© 2023 Arve-Butler, Mossberg, Kahn, Najibi, Berthold, Król, Månsson and Kahn.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Arthritis Rheum. 2011 Feb;63(2):556-67
pubmed: 21280010
Ann Rheum Dis. 1989 Feb;48(2):114-7
pubmed: 2784658
J Rheumatol. 2003 Oct;30(10):2275-82
pubmed: 14528529
J Autoimmun. 2009 Nov-Dec;33(3-4):247-54
pubmed: 19846275
J Rheumatol. 2009 Aug;36(8):1737-43
pubmed: 19567622
Rheumatology (Oxford). 2021 Jun 18;60(6):2896-2905
pubmed: 33274366
Pediatr Rheumatol Online J. 2017 Aug 18;15(1):66
pubmed: 28821293
Nat Rev Rheumatol. 2009 Nov;5(11):616-26
pubmed: 19806151
Arthritis Res Ther. 2012 Apr 17;14(2):R77
pubmed: 22510425
Autoimmunity. 2019 Feb;52(1):1-11
pubmed: 30835561
J Rheumatol. 2016 Dec;43(12):2183-2188
pubmed: 27633821
Lancet. 2011 Jun 18;377(9783):2138-49
pubmed: 21684384
Clin Immunol. 2020 Feb;211:108322
pubmed: 31830532
Arthritis Rheum. 1990 Sep;33(9):1378-83
pubmed: 2403401
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):736-42
pubmed: 21813070
Rheumatology (Oxford). 2007 Jun;46(6):1015-9
pubmed: 17403710
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
N Biotechnol. 2016 Sep 25;33(5 Pt A):582-92
pubmed: 26417875
Lancet. 2007 Mar 3;369(9563):767-778
pubmed: 17336654
Immunobiology. 2016 May;221(5):634-40
pubmed: 26806845
Autoimmun Rev. 2022 Jun;21(6):103086
pubmed: 35398272
Semin Arthritis Rheum. 1996 Oct;26(2):558-63
pubmed: 8916299
Arthritis Rheum. 2011 Jan;63(1):267-75
pubmed: 20936630
J Autoimmun. 2006 Sep;27(2):81-8
pubmed: 16934956
Front Immunol. 2017 Apr 28;8:505
pubmed: 28503176
Nat Rev Rheumatol. 2021 May;17(5):257-269
pubmed: 33731872
Front Immunol. 2019 Aug 06;10:1793
pubmed: 31447836
Arthritis Res Ther. 2019 Oct 28;21(1):218
pubmed: 31661011
Ophthalmology. 2021 Apr;128(4):598-608
pubmed: 32866542
Arthritis Rheum. 2005 Mar;52(3):826-32
pubmed: 15751057
Front Immunol. 2019 Jan 14;9:3168
pubmed: 30693002
Arthritis Rheum. 2007 Feb;56(2):647-57
pubmed: 17265500
Arthritis Rheum. 1990 Dec;33(12):1836-41
pubmed: 2261004
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319